Sethna, Z., Guasp, P., Reiche, C., Milighetti, M., Ceglia, N., Patterson, E., Lihm, J., Payne, G., Lyudovyk, O., Rojas, L. A., Pang, N., Ohmoto, A., Amisaki, M., Zebboudj, A., Odgerel, Z., Bruno, E. M., Zhang, S. L., Cheng, C., Elhanati, Y., Derhovanessian, E., Manning, L., Müller, F., Rhee, I., Yadav, M., Merghoub, T., Wolchok, J. D., Basturk, O., Gönen, M., Epstein, A. S., Momtaz, P., Park, W., Sugarman, R., Varghese, A. M., Won, E., Desai, A., Wei, A. C., D’Angelica, M. I., Kingham, T. P., Soares, K. C., Jarnagin, W. R., Drebin, J., O’Reilly, E. M., Mellman, I., Åžahin, U., Türeci, Ã., Greenbaum, B. D., Balachandran, V. P. (2025). RNA neoantigen vaccines prime long-lived CD8+ T cells in pancreatic cancer. Nature. https://doi.org/10.1038/s41586-024-08508-4